The efficacy of commercial smartwatches with a blood pressure-monitoring feature: A pilot randomized controlled trial

Hsin Yen Yen, Wen Hsin Huang

研究成果: 雜誌貢獻文章同行評審

摘要

Purpose: The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure-monitoring feature. Design: A randomized controlled trial. Methods: Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure-monitoring feature for 12 weeks. Data were collected using Omron HEM-907, Inbody 270S, and the International Physical Activity Questionnaire. Findings: Results revealed a significant effect and group-by-time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure-monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion: Using commercial smartwatches with a blood pressure-monitoring feature is a feasible approach to support self-management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance: Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self-monitoring and healthy behavior modifications.

原文英語
期刊Journal of Nursing Scholarship
DOIs
出版狀態接受/付印 - 2021

ASJC Scopus subject areas

  • 護理(全部)

指紋

深入研究「The efficacy of commercial smartwatches with a blood pressure-monitoring feature: A pilot randomized controlled trial」主題。共同形成了獨特的指紋。

引用此